What is a common treatment for respiratory distress syndrome in neonates?

Respiratory distress syndrome (RDS) is a common condition in premature neonates, primarily caused by insufficient surfactant in the lungs, leading to alveolar collapse and impaired gas exchange. The treatment of choice for RDS focuses on providing adequate respiratory support to maintain oxygenation and ventilation.

Continuous positive airway pressure (CPAP) is a widely used method in the management of RDS, as it helps keep the alveoli open and reduces the work of breathing by delivering a constant pressure throughout the respiratory cycle. This support is crucial for improving oxygenation and preventing further respiratory complications. In cases where CPAP is insufficient or the infant's condition deteriorates, intubation may become necessary to provide mechanical ventilation, ensuring that adequate respiratory support is delivered.

The other approaches, while they might play a role in the overall management of neonates with respiratory issues, do not address the underlying problem of RDS as effectively as continuous CPAP or intubation. High-flow nasal cannula may also provide some level of oxygen support but is generally not sufficient for the significant respiratory distress seen in RDS. Oral corticosteroids are typically not used in the acute management of RDS in neonates and may be reserved for specific situations, such as preterm labor